Trial Profile
A study to evaluate whether gender, physical and genetic differences affect chelation efficacy and to determine desferasirox plasma concentrations.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Feb 2016
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Beta-thalassaemia
- Focus Therapeutic Use
- 04 Feb 2016 New trial record